Clinical Trial Update: Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

This ongoing Phase 1/2 clinical trial is evaluating venetoclax in combination chemotherapy for newly diagnosed or relapsed/refractory acute myeloid leukemia, in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Venetoclax (venetoclax)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: High Risk Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: RECRUITING